ArticleJournal of the Chinese Medical Association : JCMA2022

The clinical impacts of molecular subtyping by multigene assay on hormone receptor-positive breast cancers.

Yeng-Ling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.